ChromaDex (CDXC) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ChromaDex Earnings Summary ChromaDex issued Q3 2024 earnings on October 31, 2024, reporting an EPS of $0.02, which topped the consensus estimate of $0.01 by $0.02. Quarterly revenue was reported to be $25.58 million, above the consensus estimate of $23.70 million. With a trailing EPS of $0.10 and a P/E Ratio of 787.29, ChromaDex's earnings are expected to grow 200.00% next year, from $0.04 to $0.12 per share. Latest Q3 Earnings DateOct. 31EstimatedConsensus EPS (Oct. 31) $0.01 Actual EPS (Oct. 31) $0.02 Beat By $0.02 Actual Revenue (Oct. 31) $25.58MQ3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Quarterly Report (10-Q)Slide DeckFull Screen Slide DeckPowered by Get ChromaDex Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ChromaDex and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCDXC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CDXC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ChromaDex Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$0.00$0.03$0.02Q2 20252$0.01$0.04$0.03Q3 20252$0.02$0.04$0.03Q4 20252$0.03$0.06$0.05 FY 2025 8 $0.06 $0.17 $0.12 Q1 20262$0.01$0.05$0.03Q2 20262$0.02$0.06$0.04Q3 20262$0.04$0.08$0.06Q4 20262$0.06$0.11$0.09 ChromaDex Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/31/2024Q3 2024$0.0050$0.02+$0.0150$0.02$23.70M$25.58M5/8/2024Q1 2024-$0.03-$0.01+$0.02-$0.01$22.35M$22.15M11/8/2023Q3 2023-$0.03-$0.01+$0.02-$0.01$20.61M$19.50M8/9/2023Q2 2023-$0.04-$0.03+$0.01-$0.03$19.49M$20.32M ChromaDex Earnings - Frequently Asked Questions When did ChromaDex announce their last quarterly earnings? ChromaDex (NASDAQ:CDXC) last announced its quarterly earning data on Thursday, October 31, 2024. Learn more on CDXC's earnings history. Did ChromaDex beat their earnings estimates last quarter? In the previous quarter, ChromaDex (NASDAQ:CDXC) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.02. Learn more on analysts' earnings estimate vs. CDXC's actual earnings. How can I listen to ChromaDex's earnings conference call? The conference call for ChromaDex's latest earnings report can be listened to online. Listen to Conference Call How can I read ChromaDex's conference call transcript? The conference call transcript for ChromaDex's latest earnings report can be read online. Read Transcript How much revenue does ChromaDex generate each year? ChromaDex (NASDAQ:CDXC) has a recorded annual revenue of $99.60 million. How much profit does ChromaDex generate each year? ChromaDex (NASDAQ:CDXC) has a recorded net income of -$4.94 million. CDXC has generated $0.10 earnings per share over the last four quarters. What is ChromaDex's price-to-earnings ratio? ChromaDex (NASDAQ:CDXC) has a trailing price-to-earnings ratio of 787.29. What is ChromaDex's EPS forecast for next year? ChromaDex's earnings are expected to grow from $0.04 per share to $0.12 per share in the next year, which is a 200.00% increase. More Earnings Resources from MarketBeat Related Companies Lyell Immunopharma Earnings Results Apellis Pharmaceuticals Earnings Results Organon & Co. Earnings Results ImmunityBio Earnings Results Amneal Pharmaceuticals Earnings Results Xenon Pharmaceuticals Earnings Results Mirum Pharmaceuticals Earnings Results Arrowhead Pharmaceuticals Earnings Results NewAmsterdam Pharma Earnings Results Belite Bio Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:CDXC) was last updated on 6/9/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Knows Exactly What He's DoingREVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChromaDex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ChromaDex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDXC Stock Free CDXC Stock Alerts